Korro Bio, Inc (KRRO): Fair Value Consensus
Korro Bio, Inc. (KRRO) is developing flexible methods for correcting protein malfunctions, targeting the genetic therapy segment. This chart shows the current share price on GURU.Markets is 21.21, which correlates with the expansion of the workforce through the recruitment of leading bioinformaticians. The stability of the R&D center is supported by a stock option system, while the business model relies on collaboration with medical centers and pharma behemoths.
Metric breakdowns and analytics for Korro Bio, Inc. (KRRO)
The potential of the OPERA platform for the safe correction of genetic defects establishes Korro Bio, Inc. (KRRO) as a high-reputation innovator in RNA editing. This analyst consensus chart visualizes the weighted average fair value of the stock, aggregating expert forecasts to identify pivot points in expectations, which allows investors to assess the risk of overpaying for capital during peak price action.
